EP Patent

EP0983765B1 — Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance

Assigned to Asubio Pharma Co Ltd · Expires 2006-09-27 · 20y expired

What this patent protects

It is an object of the present invention to provide a pharmaceutical composition for effectively preventing or improving diseases having vascular dysfunction associated with insulin resistance. The present invention provides pharmaceutical compositions for preventing or treating …

USPTO Abstract

It is an object of the present invention to provide a pharmaceutical composition for effectively preventing or improving diseases having vascular dysfunction associated with insulin resistance. The present invention provides pharmaceutical compositions for preventing or treating diseases having vascular dysfunction associated with insulin resistance, comprising as an active ingredient a compound of the formula (I): <CHEM> wherein R<1> and R<2> each represents a hydrogen atom or taken together with each other represent a single bond, while R<3> represents -CH(OH)CH(OH)CH3, -CH(OCOCH3)CH(OCOCH3)CH3, -CH3, -CH2OH or a phenyl group when R<1> and R<2> each represents a hydrogen atom, or -COCH(OH)CH3 when R<1> and R<2> together represents a single bond, or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0983765B1
Jurisdiction
EP
Classification
Expires
2006-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Asubio Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.